NOV 28, 2015 5:50 PM PST

Alzheimer's Disease Discovery Could Lead to New Treatments

WRITTEN BY: Julianne Chiaet
Scientists at the University of New South Wales have identified how connections between brain cells are destroyed in the early stages of Alzheimer’s disease. Their findings were published on November 27 in the journal Nature Communications.

Over 100 years have passed since Alzheimer’s disease was discovered, yet the mechanisms behind the disease have remained poorly understood. 
 
Alzheimer's disease is the most common form of dementia
Alzheimer’s disease is a progressive disease that destroys memory and causes cognitive decline. One of the key signs of early Alzheimer’s is the loss of synapses, structures that connect neurons in the brain. Synapses allow information to flow between neurons. They are required for all brain functions, particularly for learning and forming memories. Loss of synapses occur before clinical symptoms of Alzheimer’s are apparent and long before the nerve cells themselves die.

Molecular biologist Vladimir Sytnyk led a team of researchers to investigate brain changes related to Alzheimer’s. They focused on a protein in the brain called neural cell adhesion molecule 2 (NCAM2). NCAM2 is important for brain development and necessary in adult brains. Previous studies have indicated a link between NCAM2 and Alzheimer’s disease. The team now wanted to know whether the disease influenced levels of NCAM2 in synapses. 
?
 

The team studied frozen post-mortem hippocampus brain tissue of Alzheimer’s disease patients and non-affected controls. They found that NCAM2 levels in synapses were lower in Alzheimer’s suffers than in healthy patients. 

The team additionally used mice to find whether a different protein, beta-amyloid, interacted with NCAM2 in the brain. Beta-amyloid is the main component of the amyloid plaques found in the brains of Alzheimer patients. These plaques accumulate outside neurons and destroy them. The scientists observed that beta-amyloid broke down NCAM2.

Overall, the data provides a mechanical explanation for the NCAM2 changes in synapses in Alzheimer’s disease brains: beta-amyloid causes synaptic loss and the breakdown of protein NCAM2. 

The researchers hope the finding will allow for the future development of more targeted preventative treatments. "It opens up a new avenue for research on possible treatments that can prevent the destruction of NCAM2 in the brain," Sytnyk said.

Source: Journal article and University of New South Wales press release via EurekAlert  
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
SEP 29, 2021
Cardiology
New Evidence on the Association between Nitrogen Dioxide Emissions and Cardiovascular Disease
SEP 29, 2021
New Evidence on the Association between Nitrogen Dioxide Emissions and Cardiovascular Disease
Human activities such as burning fossil fuels have been the primary driver of climate change over the past two centuries ...
OCT 05, 2021
Drug Discovery & Development
Drug repurposing for COVID-19
OCT 05, 2021
Drug repurposing for COVID-19
The coronavirus disease that began in 2019 (COVID-19) has infected nearly 235 million individuals and led to t ...
OCT 09, 2021
Cardiology
Elevated Blood Pressure Linked to Decline in Brain Health
OCT 09, 2021
Elevated Blood Pressure Linked to Decline in Brain Health
New research has confirmed previous work indicating that there's a connection between elevated blood pressure and cognit ...
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
OCT 17, 2021
Technology
How Do People Feel About Facial Recognition Tools In Healthcare?
OCT 17, 2021
How Do People Feel About Facial Recognition Tools In Healthcare?
Facial image data and recognition tools have become a nearly ubiquitous part of our society: we use it to unlock smartph ...
OCT 19, 2021
Cell & Molecular Biology
Mouse Fathers Passed Immunity Onto Offpsring After Infection
OCT 19, 2021
Mouse Fathers Passed Immunity Onto Offpsring After Infection
Parents pass their genes on to their children. But they can pass down other things too with epigenetic marks, chemical t ...
Loading Comments...